Norbert Stefan

Norbert Stefan's AcademicInfluence.com Rankings

Norbert Stefan

Philosophy

#6996

World Rank

#10136

Historical Rank

Logic

#4077

World Rank

#5324

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Norbert Stefan's Degrees

PhD Medical Science Ludwig Maximilian University of Munich

Why Is Norbert Stefan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Norbert Stefan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification and characterization of metabolically benign obesity in humans. (2008) (1025)
Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach (2013) (784)
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. (2002) (714)
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. (2009) (689)
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. (2013) (577)
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. (2002) (567)
Causes and metabolic consequences of Fatty liver. (2008) (506)
Obesity and impaired metabolic health in patients with COVID-19 (2020) (481)
Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. (2006) (477)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. (2019) (463)
The role of hepatokines in metabolism (2013) (413)
Impact of Age on the Relationships of Brown Adipose Tissue With Sex and Adiposity in Humans (2010) (351)
Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes (2008) (350)
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. (2017) (346)
Adiponectin--its role in metabolism and beyond. (2002) (310)
Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene (2009) (302)
Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. (2002) (302)
Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke (2008) (292)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production (2008) (280)
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion (2008) (275)
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease (2008) (262)
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms (2007) (250)
Causes, consequences, and treatment of metabolically unhealthy fat distribution. (2020) (246)
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19 (2021) (245)
Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis (2016) (231)
Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study (2010) (230)
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. (2018) (219)
Metabolically healthy obesity: the low-hanging fruit in obesity treatment? (2017) (217)
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans (2016) (207)
The impact of insulin resistance on the kidney and vasculature (2016) (197)
Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat (2005) (190)
Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. (2003) (186)
The Metabolically Benign and Malignant Fatty Liver (2011) (183)
Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function (2007) (181)
Variation in the FTO gene influences food intake but not energy expenditure. (2008) (177)
Muscle-Derived Angiopoietin-Like Protein 4 Is Induced by Fatty Acids via Peroxisome Proliferator–Activated Receptor (PPAR)-δ and Is of Metabolic Relevance in Humans (2009) (176)
Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial (2011) (169)
Intermuscular adipose tissue (IMAT): Association with other adipose tissue compartments and insulin sensitivity (2009) (167)
Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat‐selective MRI and volume‐localized 1H‐MR spectroscopy (2006) (167)
Phenotypes of prediabetes and stratification of cardiometabolic risk. (2016) (159)
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study (2008) (155)
Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. (2004) (154)
Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. (2007) (150)
The impact of liver fat vs visceral fat in determining categories of prediabetes (2010) (146)
Individual Stearoyl-CoA Desaturase 1 Expression Modulates Endoplasmic Reticulum Stress and Inflammation in Human Myotubes and Is Associated With Skeletal Muscle Lipid Storage and Insulin Sensitivity In Vivo (2009) (144)
Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in Humans (2010) (143)
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans (2013) (141)
Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI / MRS study (2005) (139)
Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans (2009) (138)
High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention (2007) (138)
Effects of a lifestyle intervention in metabolically benign and malign obesity (2011) (136)
Central Insulin Administration Improves Whole-Body Insulin Sensitivity via Hypothalamus and Parasympathetic Outputs in Men (2014) (131)
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial (2019) (129)
Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. (2009) (128)
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes (2020) (125)
Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function (2008) (125)
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. (2008) (125)
Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy (2019) (125)
Impact of Variation in the FTO Gene on Whole Body Fat Distribution, Ectopic Fat, and Weight Loss (2008) (122)
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—the EUGENE2 study (2008) (119)
Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. (2004) (118)
Plasma adiponectin and endogenous glucose production in humans. (2003) (118)
Lifestyle intervention in individuals with normal versus impaired glucose tolerance (2007) (116)
The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism (2002) (110)
Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. (2010) (109)
Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion (2009) (108)
Quantification of Pancreatic Lipomatosis and Liver Steatosis by MRI: Comparison of In/Opposed-Phase and Spectral-Spatial Excitation Techniques (2008) (104)
The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. (2006) (104)
Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver (2013) (101)
Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans (2008) (101)
A global view of the interplay between non-alcoholic fatty liver disease and diabetes. (2022) (100)
(1)H MR spectroscopy of skeletal muscle, liver and bone marrow. (2008) (98)
Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived ‘Browning’ Factor Irisin, Determines Insulin Sensitivity (2013) (98)
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease (2017) (97)
Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes (2001) (94)
Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study (2009) (94)
Leptin down‐regulates insulin action through phosphorylation of serine‐318 in insulin receptor substrate 1 (2006) (93)
[S2k Guideline non-alcoholic fatty liver disease]. (2015) (92)
Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction (2008) (92)
T2* Relaxometry in Liver, Pancreas, and Spleen in a Healthy Cohort of One Hundred Twenty-Nine Subjects–Correlation With Age, Gender, and Serum Ferritin (2008) (90)
Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion (2017) (89)
Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. (2011) (88)
A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion (2009) (85)
Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects (2006) (85)
Body adiposity index, body fat content and incidence of type 2 diabetes (2012) (84)
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. (2014) (83)
Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. (2002) (83)
Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications. (2016) (83)
The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. (2001) (82)
Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes. (2015) (82)
Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion (2000) (81)
Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. (2005) (81)
Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene. (2001) (81)
Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study. (2008) (81)
The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. (2009) (80)
Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research (2013) (78)
Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. (2008) (77)
Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men (2017) (74)
Low plasma adiponectin concentrations do not predict weight gain in humans. (2002) (71)
Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. (2004) (71)
Genetic determinants of insulin action in polycystic ovary syndrome. (2005) (70)
Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies (2014) (67)
High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. (2009) (66)
Gene Variants of TCF7L2 Influence Weight Loss and Body Composition During Lifestyle Intervention in a Population at Risk for Type 2 Diabetes (2009) (66)
High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. (2012) (65)
A Candidate Type 2 Diabetes Polymorphism Near the HHEX Locus Affects Acute Glucose-Stimulated Insulin Release in European Populations (2008) (64)
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms (2009) (63)
Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired β-Cell Function (2010) (63)
Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci (2016) (63)
Variant near ADAMTS9 Known to Associate with Type 2 Diabetes Is Related to Insulin Resistance in Offspring of Type 2 Diabetes Patients—EUGENE2 Study (2009) (63)
Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. (2001) (63)
Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension (2018) (63)
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes (2015) (62)
RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. (2009) (61)
High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention (2011) (61)
Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. (2001) (58)
Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion (2010) (57)
Effects of resveratrol supplementation on liver fat content in overweight and insulin‐resistant subjects: A randomized, double‐blind, placebo‐controlled clinical trial (2018) (57)
Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. (2011) (55)
Quantitative Analysis of Adipose Tissue in Single Transverse Slices for Estimation of Volumes of Relevant Fat Tissue Compartments: A Study in a Large Cohort of Subjects at Risk for Type 2 Diabetes by MRI With Comparison to Anthropometric Data (2010) (55)
Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study (2015) (54)
Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance (2002) (53)
Correlation of Brown Adipose Tissue with Other Body Fat Compartments and Patient Characteristics: A Retrospective Analysis in a Large Patient Cohort Using PET/CT. (2018) (51)
Novel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes (2008) (50)
TGF-β Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle (2016) (50)
A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes (2015) (50)
A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance. (2006) (49)
Metabolic Signatures of Cultured Human Adipocytes from Metabolically Healthy versus Unhealthy Obese Individuals (2014) (49)
The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. (2018) (49)
The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. (2005) (48)
Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. (2003) (47)
SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention – the TULIP Study (2008) (47)
Plasma adiponectin levels are not associated with fat oxidation in humans. (2002) (47)
Exaggerated insulin secretion in Pima Indians and African‐Americans but higher insulin resistance in Pima Indians compared to African‐Americans and Caucasians (2004) (46)
Impairment of GLP1‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia (2012) (46)
New Imaging Techniques of Fat, Muscle and Liver within the Context of Determining Insulin Sensitivity (2006) (46)
The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. (2009) (45)
Glucose-Raising Genetic Variants in MADD and ADCY5 Impair Conversion of Proinsulin to Insulin (2011) (44)
PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans (2014) (44)
Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells (2014) (44)
mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action (2009) (43)
Glycemia Determines the Effect of Type 2 Diabetes Risk Genes on Insulin Secretion (2010) (43)
Interaction effect between common polymorphisms in PPARγ2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity (2002) (43)
Insulin sensitivity and liver fat: role of iron load. (2011) (42)
Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex‐specific Manner (2008) (42)
Association of the FTO rs9939609 Single Nucleotide Polymorphism With C‐reactive Protein Levels (2009) (41)
Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. (2003) (40)
Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. (2016) (39)
Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults (2014) (39)
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content (2012) (38)
Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene. (2005) (37)
Solutions for low and high accuracy mass spectrometric data matching: a data-driven annotation strategy in nontargeted metabolomics. (2015) (36)
Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice (2017) (36)
Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans (2014) (36)
An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality (2021) (36)
Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors (2019) (35)
Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. (2011) (35)
Fraction of unsaturated fatty acids in visceral adipose tissue (VAT) is lower in subjects with high total VAT volume – a combined 1H MRS and volumetric MRI study in male subjects (2013) (34)
Novel Obesity Risk Loci Do Not Determine Distribution of Body Fat Depots: A Whole‐body MRI/MRS study (2010) (34)
Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12Ala. (2003) (34)
Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes. (2009) (34)
Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene–gene interactions (2006) (34)
Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade (2020) (34)
Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus (2019) (33)
Variants in the CD36 Gene Locus Determine Whole‐Body Adiposity, but Have No Independent Effect on Insulin Sensitivity (2011) (33)
Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians. (2004) (33)
C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity. (2004) (32)
Environmental and Genetic Determinants of Fatty Liver in Humans (2010) (31)
The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. (2010) (31)
Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B (2011) (30)
Reduced adiponectin serum levels in smokers. (2005) (30)
Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes (2007) (30)
Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. (2011) (30)
Cholesterol Synthesis Is Associated with Hepatic Lipid Content and Dependent on Fructose/Glucose Intake in Healthy Humans (2011) (29)
Metabolic disorders, COVID-19 and vaccine-breakthrough infections (2021) (29)
Acute stimulation of leptin concentrations in humans during hyperglycemic hyperinsulinemia. Influence of free fatty acids and fasting (2001) (29)
Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. (2010) (29)
The risk allele load accelerates the age-dependent decline in beta cell function (2009) (28)
Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans (2012) (28)
The D299G/T399I Toll-Like Receptor 4 Variant Associates with Body and Liver Fat: Results from the TULIP and METSIM Studies (2010) (28)
Intra‐ and interindividual variability of fatty acid unsaturation in six different human adipose tissue compartments assessed by 1H‐MRS in vivo at 3 T (2017) (28)
Cardiorespiratory fitness determines the reduction in blood pressure and insulin resistance during lifestyle intervention (2011) (27)
Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects (2007) (27)
The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. (2010) (26)
PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors (2005) (26)
Sex hormone-binding globulin and risk of type 2 diabetes. (2009) (26)
Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1☆ (2014) (25)
Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity, Obesity-Related Insulin Resistance, and Circulating Leptin Levels (2012) (25)
Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. (2013) (25)
Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. (2001) (25)
Allele Summation of Diabetes Risk Genes Predicts Impaired Glucose Tolerance in Female and Obese Individuals (2012) (25)
Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase (2010) (25)
Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced β-cell function in non-diabetic subjects (2009) (25)
A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation (2016) (24)
Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial. (2021) (24)
Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study (2015) (24)
Metabolically Healthy and Unhealthy Normal Weight and Obesity (2020) (24)
Interscapular fat is strongly associated with insulin resistance. (2010) (23)
Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes. (2011) (23)
Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content (2016) (23)
Adiponectin Oligomers and Ectopic Fat in Liver and Skeletal Muscle in Humans (2009) (23)
Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study (2017) (23)
Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. (2008) (23)
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes (2021) (23)
The -8503 G/A polymorphism of the adiponectin receptor 1 gene is associated with insulin sensitivity dependent on adiposity. (2006) (23)
Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight. (2004) (23)
Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites (2007) (22)
Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion. (2013) (22)
Impact of Different Fat Depots on Insulin Sensitivity: Predominant Role of Liver Fat (2007) (22)
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. (2013) (22)
Genetic variation within the NR1H2 gene encoding liver X receptor β associates with insulin secretion in subjects at increased risk for type 2 diabetes (2010) (22)
Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance (2016) (21)
Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. (2008) (21)
An extended fatty liver index to predict non-alcoholic fatty liver disease. (2017) (21)
The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. (2009) (20)
Elevated circulating follistatin associates with an increased risk of type 2 diabetes (2021) (20)
The Body Adiposity Index and the Sexual Dimorphism in Body Fat (2011) (20)
The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition. (2008) (20)
Adiponectin in youth: response to Bacha et al. (2004) (19)
Identification and Characterization of Metabolically Benign Obesity in Humans (2009) (19)
Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes (2010) (19)
Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. (2009) (18)
Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies (2008) (18)
Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans (2004) (18)
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms (2007) (17)
AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study. (2009) (17)
Global trends in body-mass index (2011) (17)
Association of fetuin-A level and diabetes risk. (2008) (17)
The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A (2017) (17)
Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity. (2016) (16)
Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers (2015) (16)
Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans (2016) (16)
Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study. (2019) (15)
Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention (2019) (15)
Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS) (2021) (15)
Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) Gene and Metabolic Risk Factors in the EPIC-Potsdam Study (2012) (14)
The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention (2010) (14)
Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis (2018) (14)
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity (2017) (14)
Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity (2013) (14)
Nonalcoholic Fatty Liver Disease and Mortality. (2018) (13)
Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation (2016) (13)
Liver-targeting drugs and their effect on blood glucose and hepatic lipids (2021) (12)
Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. (2006) (12)
The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function (2004) (12)
Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry (2022) (12)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Psychological effects of prevention: do participants of a type 2 diabetes prevention program experience increased mental distress? (2009) (11)
Periaortic Adipose Tissue Compared With Peribrachial Adipose Tissue Mass as Markers and Possible Modulators of Cardiometabolic Risk (2018) (11)
Genetic determination of body fat distribution and the attributive influence on metabolism (2017) (11)
Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans (2014) (11)
Metabolomic Characteristics of Fatty Pancreas (2018) (11)
Cardiovascular disease in patients with non-alcoholic fatty liver disease (2012) (10)
Elevated circulating Glutamate associates with subclinical Atherosclerosis independently of established Risk Markers: a cross-sectional study. (2020) (10)
The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals. (2008) (10)
Sex-Specific Associations of Testosterone With Metabolic Traits (2019) (9)
Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance (2021) (9)
Normalized Indices Derived from Visceral Adipose Mass Assessed by Magnetic Resonance Imaging and Their Correlation with Markers for Insulin Resistance and Prediabetes (2020) (9)
Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans (2000) (9)
Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk. (2014) (9)
The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells (2021) (9)
Genetic variability of procolipase associates with altered insulin secretion in non-diabetic Caucasians. (2008) (9)
Autoimmune thrombocytopenia associated with Borrelia burgdorferi. (1999) (9)
Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion (2021) (8)
Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. (2014) (8)
Fat-distribution Patterns and Future Type-2 Diabetes. (2022) (8)
No association between variation in the NR4A1 gene locus and metabolic traits in white subjects at increased risk for type 2 diabetes (2010) (8)
Association of Common Genetic Variation in The FOXO1 Gene with β-Cell Dysfunction, Impaired Glucose Tolerance, And Type 2 Diabetes (2009) (8)
Insulin Resistant Phenotype of Polycystic Ovary Syndrome does not Seem to be Caused by Variation in FTO (2012) (7)
Fetuin-A and risk of diabetes-related vascular complications: a prospective study (2022) (7)
The role of hepatokines in NAFLD. (2023) (7)
The genetic influence on body fat distribution (2013) (7)
Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations (2017) (7)
Wrapper- and Ensemble-Based Feature Subset Selection Methods for Biomarker Discovery in Targeted Metabolomics (2011) (7)
Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus (2020) (7)
FTO Genotype Interacts with Improvement in Aerobic Fitness on Body Weight Loss During Lifestyle Intervention (2016) (6)
Inferring Disease-Related Metabolite Dependencies with a Bayesian Optimization Algorithm (2012) (6)
A Polygenic Risk Score of Lipolysis-Increasing Alleles Determines Visceral Fat Mass and Proinsulin Conversion (2019) (6)
Insulin resistance and congestive heart failure. (2005) (6)
The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. (2018) (6)
In vitro responsiveness of human muscle cell peroxisome proliferator‐activated receptor δ reflects donors’ insulin sensitivity in vivo (2011) (6)
Selective association of plasma non-esterified fatty acid species with circulating interleukin-8 concentrations in humans. (2008) (6)
Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes. (2021) (6)
The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention (2007) (6)
Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective (2019) (6)
Regulation of synovial adipocytokines. (2004) (6)
Measures of adiposity and fat distribution and risk of diabetes. (2013) (6)
Cardiorespiratory fitness, adiposity, and mortality. (2008) (6)
AMPK subunits harbor largely non-overlapping genetic determinants for body fat mass, glucose- and cholesterol metabolism. (2019) (6)
High Baseline Vitamin C Levels Do Not Prevent a Positive Outcome of a Lifestyle Intervention (2009) (5)
Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood (2021) (5)
Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men". (2010) (5)
Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. (2018) (5)
A 60 minute hyperglycemic clamp is sufficient to assess both phases of insulin secretion. (2000) (5)
A novel functional polymorphism (−336A/G) in the promoter of the partitioning-defective protein-6α gene is associated with increased glucose tolerance and lower concentrations of serum non-esterified fatty acids (2005) (5)
Role of ectopic fat in the pathogenesis of insulin resistance (2009) (5)
Risk-stratified lifestyle intervention to prevent type 2 diabetes (2021) (5)
SARS-CoV-2 fires up inflammation in adipose tissue (2022) (4)
Diabetes and Fatty Liver. (2019) (4)
Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy White population (2007) (4)
Diabetes detection from whole-body magnetic resonance imaging using deep learning. (2021) (4)
Magnetic Resonance Techniques for Assessment of Body Components (2007) (3)
[Diabetes and cancer risk]. (2012) (3)
Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion (2021) (3)
Individual stearoyl-CoA desaturase 1 (SCD1) expression modulates ER stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo (2009) (3)
[Liver volume, intrahepatic fat and body weight in the course of a lifestyle interventional study: Analysis with quantitative MR-based methods]. (2015) (3)
Perspectives in Diabetes Glucose Allostasis (2003) (3)
Gen-Umwelt-Interaktion in Pathogenese und Prävention des Diabetes mellitus Typ 2 (2007) (2)
Comment on Hedderson et al. Prepregnancy SHBG Concentrations and Risk for Subsequently Developing Gestational Diabetes Mellitus. Diabetes Care 2014;37:1296–1303 (2014) (2)
Impaired Metabolic Health and low Cardiorespiratory Fitness independently associate with Subclinical Atherosclerosis in Obesity. (2022) (2)
Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans (2018) (2)
Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation (2021) (2)
Validity of Methods Used for the Assessment of Body Components in Children (2007) (2)
The importance of brown adipose tissue. (2009) (2)
Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification. (2016) (2)
[Gene-environment interactions in the pathogenesis and prevention of type 2 diabetes mellitus]. (2007) (2)
Determinants of hepatic insulin clearance - results from a Mendelian Randomization study. (2021) (2)
Determinants of activity of brown adipose tissue in lymphoma patients (2020) (2)
Genetic Predisposition to Abdominal Adiposity and Cardiometabolic Risk. (2017) (1)
Magnetic resonance techniques for mapping fat deposits and directing therapy (2011) (1)
Subject Index Vol. 64, Suppl. 3, 2005 (2006) (1)
Fatty liver and HDL-cholesterol: just a matter of quantity? (2008) (1)
[Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]. (2011) (1)
[New aspects of nonalcoholic steatohepatitis]. (2019) (1)
AMPK subunits harbor largely non-overlapping genetic determinants for body fat mass, glucose- and cholesterol metabolism. (2019) (1)
56th EASD Annual Meeting of the European Association for the Study of Diabetes (2020) (1)
High Baseline Vitamin C Levels Do Not Prevent a Positive Outcome of a Lifestyle Intervention (2010) (1)
Increased Insulin Clearance in PPARγ2 Pro12Ala: Indirect Evidence for Increased Hepatic Insulin Sensitivity and Reduced FFA Release (2002) (1)
1856-P: Hepatic Insulin Clearance Is Not Driven by Liver Fat but by Systemic Inflammation: A Mendelian Randomization Study (2020) (1)
Identification and Characterization of Metabolically Benign Obesity in Humans. Commentary (2008) (1)
Association of Pancreas Fat with Impaired Insulin Secretion Depends on Liver Fat and Circulating Fatty Acids (2018) (1)
133-OR: Effects of Empagliflozin on Liver Fat Content in Type 2 Diabetes: The EMLIFA001 Trial (2019) (1)
Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention (2022) (1)
Detection of diabetes from whole-body MRI using deep learning (2021) (1)
Impact of insulin resistance on vasculature and kidney (2018) (1)
Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a risk population for type 2 diabetes (2009) (1)
The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function (2004) (1)
Lifestyle Intervention: A Whole-Body Magnetic Resonance Study Determine the Change in Body Composition during PPARD Variations in (2008) (0)
Dis-coordinated activation of de novo lipogenesis and stearoyl-CoA desaturase by monosaccharides determines liver fat accumulation in humans (2011) (0)
Association of flow-mediated vasodilation with a promoter polymorphism in the gene encoding chemokine CC motif receptor 2 (CCR2) (2006) (0)
Peer Review #2 of "Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis (v0.2)" (2020) (0)
Prevention and Therapy of Obesity (2016) (0)
Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes. (2020) (0)
Phenotypes of prediabetes: pathogenesis and consequences for prediction and prevention of type 2 diabetes and cardiovascular diseases (2020) (0)
Trends in Obesity Among Low-Income Young Children. (2019) (0)
Peer Review #2 of "Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis (v0.3)" (2020) (0)
Impaired stimulated insulin-processing as predictor of non-response to lifestyle intervention (2017) (0)
Cardiorespiratory Fitness, Adiposity, and Mortality. Authors' reply (2008) (0)
Invited talk: The role of NAFLD and hepatokines in metabolism (2019) (0)
[Increased liver enzymes and metabolic risk - case 7/2011]. (2011) (0)
The TUDID Study - Background and Design of a Prospective Cohort. (2020) (0)
Invited talk: Recognising NAFLD and what should be done? (2019) (0)
Increases in Vo2max Depend On Baseline HPA, VO2max and BMI in Pre-diabetic Subjects: 1889 (2008) (0)
Metabolomic characteristics of fatty pancreas (2018) (0)
Genome-Wide and Abdominal Imaging Data Characterizes Common Alleles Associated with Higher BMI and Subcutaneous Fat but Less Liver Fat and Lower Risk of Type 2 Diabetes (2018) (0)
Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention (2019) (0)
Differential apelin mRNA expression in placenta of women with gestational diabetes (GDM) (2016) (0)
Breastfeeding duration associates with lower intima media thickness in women without history of gestational diabetes (2023) (0)
Fettleber und Diabetes: Pathomechanismen (2020) (0)
Stk25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and NAFLD in mice (2018) (0)
protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine (2017) (0)
Supplementary material : An extended fatty liver index to predict non-alcoholic fatty liver disease (2017) (0)
TLR2/4 dependent and independent effects of the hepatokine fetuin-A in islets (2015) (0)
Circulating follistatin predicts type 2 diabetes risk (2020) (0)
Adiponectin induces phosphoryllation of acetyl coenzyme A carboxylase in human islets but does not affect insulin secretory function or beta-cell apoptosis (2005) (0)
The Common Food Additive Carrageenan Increases Intestinal Permeability without Affecting Whole-Body Insulin Sensitivity in Humans—Results from a Randomized, Double-Blind Crossover Study (2018) (0)
[New pharmacological treatment options for nonalcoholic fatty liver disease]. (2020) (0)
The hepatokine fetuin-A associates with insulin resistance and induces inflammation but selectively improves cAMP-dependent insulin secretion of human islets (2014) (0)
Peer Review #2 of "Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis (v0.1)" (2020) (0)
Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories (2023) (0)
Relevance of visceral adipose tissue and intrahepatic lipids in the pathogenesis of insulin resistance – a cross-sectional study (2005) (0)
Interscapular fat is strongly associated with insulin resistance (2010) (0)
Human fat depots show distinct quantitative, qualitative and functional inter-individual differences (2018) (0)
Detection and Characterization of Phosphorylation and other molecular modifications of Fetuin A in Human Blood (2021) (0)
Fiber intake influences the association between variants in TCF7L2 and body weight reduction during a lifestyle intervention and at long-term follow-up (2017) (0)
Systematic review of precision subclassification of type 2 diabetes (2023) (0)
Invited talk: Prediabetes phenotypes improve prediction and prevention of type 2 diabetes (2019) (0)
Automated shape-independent assessment of the spatial distribution of proton density fat fraction in vertebral bone marrow. (2023) (0)
Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans (2018) (0)
Adipositas und Diabetes mellitus (2018) (0)
Plasma proteomic profiles in prediabetes reversing to normoglycemia or progressing to diabetes in a year – a cross-sectional and prospective analysis (2023) (0)
Fat mass as risk factor: Why overweight and obesity are adverse to the COVID-19 progression [German] (2020) (0)
102-OR: Detection of Diabetes from Whole-Body Magnetic Resonance Imaging Using Deep Learning (2020) (0)
Linkage disequilibrium data (D’, r 2 ) between the 14 tagging SNPs of the MAP4K4 locus. (2012) (0)
Differences in insulin sensitivity and adipose tissue distribution in obese subjects - is there a benign form of adiposity? (2011) (0)
The I148 M variant in PNPLA3 is associated with altered hepatic lipid composition in humans (2014) (0)
Diabetes and Fatty Liver. (2022) (0)
Interscapular fat is associated with impaired glucose tolerance and insulin resistance independent of visceral fat mass (2022) (0)
2309-PUB: Postprandial Thermogenesis Is Reduced in Obesity (2020) (0)
Empagliflozin effectively reduces liver fat content in type 2 diabetes (2019) (0)
Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer (2022) (0)
The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A (2017) (0)
118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism (2022) (0)
Screening for advanced liver fibrosis in overweight and obese patients with NAFLD (2022) (0)
Autoimmune Thrombocytopenia Associated with Borrelia (1999) (0)
Blood Culture Collection for Suspected Bacteremia (0)
Regulation of synovial adipocytokines. Authors' reply (2004) (0)
Subject Index Vol. 66, Suppl. 1, 2006 (2007) (0)
Insulin clearance is associated with insulin sensitivity independent from liver fat (2019) (0)
Predictors for Successful BMI Reduction by Lifestyle Intervention in Subjects with Increased Risk of Type 2 Diabetes: 2140 (2007) (0)
Brain Insulin Sensitivity Predicts Adiposity—Nine-Year Results of the Tulip Study (2018) (0)
Genetic and environmental determinants of intrahepatic lipids (2007) (0)
Author's response to reviews Title: Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion Authors: (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Norbert Stefan?

Norbert Stefan is affiliated with the following schools:

Ludwig Maximilian University of Munich
University of Tübingen
Osaka University
Harvard University